Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Parigger

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Oncotarget|September 7, 2019
Mouse models to decipher anti-tumor immunityThomas Parigger, Richard Greil, Nadja Zaborsky
International Journal of Molecular Sciences|September 10, 2021
A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case ReportMarkus Steiner, Franz J Gassner, Thomas Parigger, et al.
Scientific Reports|November 10, 2025
IGHV1 usage is associated with lymphadenopathy and aggressive disease in the TCL1 mouse model for chronic lymphocytic leukemiaStephan Drothler, Christian Scherhäufl, Carina Suete, et al.
Oncotarget|January 20, 2016
DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistanceWolfgang Gruber, Martin Hutzinger, Dominik Patrick Elmer, et al.
International Journal of Molecular Sciences|July 2, 2021
Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic LeukemiaThomas Parigger, Franz Josef Gassner, Christian Scherhäufl, et al.
Technology in Cancer Research & Treatment|May 20, 2024
Combined DNA Analysis from Stool and Blood Samples Improves Tumor Tracking and Assessment of Clonal Heterogeneity in Localized Rectal Cancer PatientsThomas Parigger, Franz Josef Gassner, Stephan Drothler, et al.
Cancers|August 27, 2021
Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog-GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO InhibitionElisabeth Peer, Sophie Karoline Aichberger, Filip Vilotic, et al.
Acta Haematologica|February 25, 2024
Oncogenic MTOR Signaling Axis Compensates BTK Inhibition in a Chronic Lymphocytic Leukemia Patient with Richter Transformation: A Case Report and Review of the LiteratureThomas Parigger, Stephan Drothler, Christian Scherhäufl, et al.
Scientific Reports|March 29, 2026
Characterization, immune cell phenotyping and differential gene expression analysis of brain metastases and primary breast cancer samplesFranz Josef Gassner, Gabriel Rinnerthaler, Vanessa Castagnaviz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Oncotarget|September 7, 2019
Mouse models to decipher anti-tumor immunityThomas Parigger, Richard Greil, Nadja Zaborsky
International Journal of Molecular Sciences|September 10, 2021
A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case ReportMarkus Steiner, Franz J Gassner, Thomas Parigger, et al.
Scientific Reports|November 10, 2025
IGHV1 usage is associated with lymphadenopathy and aggressive disease in the TCL1 mouse model for chronic lymphocytic leukemiaStephan Drothler, Christian Scherhäufl, Carina Suete, et al.
Oncotarget|January 20, 2016
DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistanceWolfgang Gruber, Martin Hutzinger, Dominik Patrick Elmer, et al.
International Journal of Molecular Sciences|July 2, 2021
Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic LeukemiaThomas Parigger, Franz Josef Gassner, Christian Scherhäufl, et al.
Technology in Cancer Research & Treatment|May 20, 2024
Combined DNA Analysis from Stool and Blood Samples Improves Tumor Tracking and Assessment of Clonal Heterogeneity in Localized Rectal Cancer PatientsThomas Parigger, Franz Josef Gassner, Stephan Drothler, et al.
Cancers|August 27, 2021
Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog-GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO InhibitionElisabeth Peer, Sophie Karoline Aichberger, Filip Vilotic, et al.
Acta Haematologica|February 25, 2024
Oncogenic MTOR Signaling Axis Compensates BTK Inhibition in a Chronic Lymphocytic Leukemia Patient with Richter Transformation: A Case Report and Review of the LiteratureThomas Parigger, Stephan Drothler, Christian Scherhäufl, et al.
Scientific Reports|March 29, 2026
Characterization, immune cell phenotyping and differential gene expression analysis of brain metastases and primary breast cancer samplesFranz Josef Gassner, Gabriel Rinnerthaler, Vanessa Castagnaviz, et al.
Pageof 1